News Release

Evolution of dual-energy CT in gout workup

Improving technology, practical changes, and more experience among radiologists and referrers account for DECT's evolving role in gout workup

Peer-Reviewed Publication

American Roentgen Ray Society

83-Year-Old Woman With No History of Gout and Serum Uric Level of 9.2 mg/dl, Who Underwent DECT (2013) of Right Foot Due to Right Ankle Pain and Swelling

image: (A) Coronal image through forefoot and (B) coronal image through ankle. Green pixels (arrows) observed in association with first and fourth metatarsophalangeal joints (A) and tibiotalar joint (B), consistent with monosodium urate deposition. Examination interpreted as positive for gout. Final clinical diagnosis by referring service was gout. Confirmatory joint aspiration not performed after DECT examination. view more 

Credit: American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

Leesburg, VA, January 27, 2022According to an article in ARRS’ American Journal of Roentgenology (AJR), technological improvements, clinical practice changes, and growing experience among radiologists and referrers alike are contributing to the evolving role of dual-energy CT (DECT) in gout workup.

When comparing DECT examinations performed for gout in 2013 and 2019, the frequency of equivocal interpretations was significantly lower in 2019, “possibly related to interval technologic improvements,” lead researcher Francis I. Baffour of Mayo Clinic in Rochester, MN concluded. “Negative examinations were less frequently followed by joint aspirations in 2019, possibly reflecting increasing clinical acceptance of the DECT results.”

Baffour and colleagues’ retrospective study included 100 consecutive adult patients who underwent DECT for gout evaluation in each of two periods, beginning in March 2013 and September 2019. DECT examinations in 2013 used a second-generation scanner (140 kV with 0.4 mm tin filter); in 2019, a third-generation scanner (150 kV with 0.6 mm tin filter) with improved spectral separation was used. Original DECT reports were classified as positive, negative, or equivocal for monosodium urate crystals indicative of gout. Joint aspirations occurring postexamination were recorded via medical record review.

Compared with the 2013 DECT examinations performed for suspected gout, those performed in 2019 had a significantly lower frequency of equivocal interpretations (16.0% vs. 33.0%, p<.001). Moreover, joint aspiration was significantly less likely to be performed after negative DECT interpretations in 2019 than in 2013 (2.1% vs. 17.4%, p=.02).

“The findings indicate an evolving role for DECT in the evaluation of gout following an institution’s routine adoption of the technology for this purpose,” the authors of this AJR article added.


North America’s first radiological society, the American Roentgen Ray Society (ARRS) remains dedicated to the advancement of medicine through the profession of medical imaging and its allied sciences. An international forum for progress in radiology since the discovery of the x-ray, ARRS maintains its mission of improving health through a community committed to advancing knowledge and skills with the world’s longest continuously published radiology journal—American Journal of Roentgenology—the ARRS Annual Meeting, InPractice magazine, topical symposia, myriad multimedia educational materials, as well as awarding scholarships via The Roentgen Fund®.

MEDIA CONTACT:

Logan K. Young, PIO

44211 Slatestone Court

Leesburg, VA 20176

703-858-4332

lyoung@arrs.org


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.